Adicet Bio, Inc. (ACET) Insider Trading
Over the last 6 months, 11 institutions increased and 10 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Jun
Oct
Jan
Jun
Oct
Apr
Context3-month price -4.2%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Klickstein Lloyddirector, officer: Chief Medical Officer | Grant | 18,300 | $9.16 |
| Jun 23, 2026 | Grissinger Michaeldirector | Grant | 4,200 | $8.10 |
| Jun 23, 2026 | Sinclair Andrewdirector | Grant | 4,200 | $8.10 |
| Jun 23, 2026 | Peng Katiedirector | Grant | 4,200 | $8.10 |
| Jun 23, 2026 | Chodakewitz Jeffreydirector | Grant | 4,200 | $8.10 |
| Jun 23, 2026 | Schor Chendirector, officer: President & CEO | Grant | 55,000 | $8.10 |
| Jun 23, 2026 | DUBIN STEVEdirector | Grant | 4,200 | $8.10 |
| Jun 23, 2026 | Aftab Blakeofficer: Chief Scientific Officer | Grant | 55,000 | $8.10 |
| Jun 23, 2026 | Klickstein Lloyddirector | Grant | 4,200 | $8.10 |
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P.10 percent owner | Buy | 74,577 | $7.04 |
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P.10 percent owner | Buy | 74,751 | $7.27 |
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P.10 percent owner | Buy | 74,268 | $7.21 |
| Apr 9, 2026 | ORBIMED ADVISORS LLC10 percent owner | Sell | 40,416 | $6.52 |
| Apr 9, 2026 | ORBIMED ADVISORS LLC10 percent owner | Sell | 32,523 | $6.29 |
| Apr 9, 2026 | ORBIMED ADVISORS LLC10 percent owner | Sell | 29,319 | $6.53 |
| Apr 9, 2026 | ORBIMED ADVISORS LLC10 percent owner | Sell | 2,400 | $6.38 |
| Mar 27, 2026 | Healey Donofficer: Chief Technology Officer | Grant | 43,361 | $6.81 |
| Mar 27, 2026 | Schor Chendirector, officer: President & CEO | Grant | 468,555 | $6.81 |
| Mar 27, 2026 | Maltzman Julia D.officer: Chief Medical Officer | Grant | 72,555 | $6.81 |
| Mar 27, 2026 | Aftab Blakeofficer: Chief Scientific Officer | Grant | 72,555 | $6.81 |
| Mar 27, 2026 | Harvey Brian Nicholasofficer: Chief Financial Officer | Grant | 43,361 | $6.81 |
| Jan 27, 2026 | Schor Chendirector, officer: President & CEO | Tax | 1,755 | $8.44 |
| Jan 27, 2026 | Healey Donofficer: Chief Technology Officer | Tax | 535 | $8.44 |
| Jan 27, 2026 | Aftab Blakeofficer: Chief Scientific Officer | Tax | 535 | $8.44 |
| Jan 27, 2026 | Harvey Brian Nicholasofficer: Chief Financial Officer | Tax | 546 | $8.44 |
| Oct 10, 2025 | ORBIMED ADVISORS LLC10 percent owner | Buy | 3,500,000 | $1.00 |
| Oct 10, 2025 | ORBIMED ADVISORS LLC10 percent owner | Buy | 1,500,000 | $1.00 |
| Jun 13, 2025 | Sinclair Andrewdirector | Grant | 26,400 | $0.78 |
| Jun 13, 2025 | Peng Katiedirector | Grant | 5,900 | — |
| Jun 13, 2025 | Peng Katiedirector | Grant | 26,400 | $0.78 |
Source: ACET SEC Form 4 filings, latest Aug 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ACET positions over the last 6 months (SEC Form 13F).
Increased
11
New positions
15
Reduced
10
Sold out
50
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Increased | 1.2M | May 15, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 1.0M | May 15, 2026 |
| FRANKLIN RESOURCES INC | Unchanged | 627K | May 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 382K | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 337K | May 15, 2026 |
| WOODLINE PARTNERS LP | Reduced | 313K | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 274K | May 15, 2026 |
| PROSIGHT MANAGEMENT, LP | Unchanged | 250K | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 235K | Mar 25, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 233K | May 14, 2026 |
| STONEPINE CAPITAL MANAGEMENT, LLC | Increased | 222K | May 14, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | Unchanged | 204K | May 15, 2026 |
| CARLYLE GROUP INC. | Unchanged | 184K | May 8, 2026 |
| NEXTBio Capital Management LP | Unchanged | 158K | May 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 118K | May 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.